Neonate characteristics after maternal use of antidepressants in late pregnancy.
about
Antidepressant prevention of postnatal depressionA meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weightThe use of psychotropic medication during pregnancy: how about the newborn?Antidepressant use in pregnancy: a critical review focused on risks and controversiesSelective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Prenatal antidepressant exposure: clinical and preclinical findings.Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.Fetal effects of psychoactive drugsPreconception care: screening and management of chronic disease and promoting psychological healthClinical issues in perinatal mental health: new developments in the detection and treatment of perinatal mood and anxiety disorders.Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.Developmental model of depression applied to prenatal depression: role of present and past life events, past emotional disorders and pregnancy stress.Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapyNational trends in antidepressant medication treatment among publicly insured pregnant womenRisk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?Does fetal exposure to SSRIs or maternal depression impact infant growth?Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.Antidepressant use in pregnant and postpartum womenTreatment of nonpsychotic major depression during pregnancy: patient safety and challengesPharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restrictionParoxetine and neonatal withdrawal syndrome.The safety of antidepressant drugs during pregnancy.Taking antidepressants during late pregnancy. How should we advise women?Depression during pregnancySelective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk?Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Mother-infant antidepressant concentrations, maternal depression, and perinatal eventsAntidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatmentMajor depression and antidepressant treatment: impact on pregnancy and neonatal outcomesSelective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.Effects of Fluoxetine on Human Embryo Development.
P2860
Q24246935-03F686BD-8DEC-4F38-9466-231DD3E5307AQ24623163-9D57D4F8-157B-40FB-BEDA-B5A775EA8769Q24625025-8C73326C-AAFF-4099-8E1C-45808625311AQ28281407-22B51859-DBEF-406E-A85A-2456381357F8Q30244451-A6D31D7E-0AEC-4BF7-8719-65B1E43E4BE7Q30249670-3F27DBF2-F519-416E-92FF-47E80D32476BQ30415540-315606CA-433E-469A-B945-068FA3323806Q30459493-6EFACE98-E278-4C84-AEA6-44063CC72CD0Q30479705-C7372A19-107A-4715-A7DD-C71F80FDCE2CQ30592032-D0F608C6-832F-462E-BE47-B2F3AB4E68B4Q30787634-11843324-1AD9-49F2-B7EC-AFB7407DC37BQ33521786-B8B9122C-98C4-4CD0-B07B-01CFE4D2A8B7Q33705235-316F9881-246B-462B-85B2-D77FCA4FB174Q33745085-257B7DD1-ED9F-4E3B-9BB3-FE9E905BFAEBQ33830556-CDB9099A-ADB4-4414-A36F-10A66EBBC23AQ33896573-8C349DCC-A17E-4119-8B49-BF8A8767A9C5Q33940520-8AA4CFE7-4E00-4FDB-AF15-4708B3BC9030Q33959971-DB5A4876-C92B-46DE-A535-2643ECEB9DB4Q34018881-FFD5FFD3-4D96-4987-AAA4-B2B6F44CA9ADQ34068023-A3A1C64A-E797-46CC-9587-49168C174792Q34237681-E291B08E-F71F-4C10-8952-266107318843Q34250131-2CD2ABA2-6AAE-44F9-8DF2-D59A67921E53Q34445231-480D9D5C-9FF1-4B9D-9713-C4B7B38AB82CQ34467757-BE630192-6606-41A4-B00D-5D573E9D9651Q34514870-705FB8B8-77CC-4201-AAD3-B617E788CAFDQ34618623-20D64F94-D3A8-487D-8874-CCA21C7CF0CEQ34661348-8EC467C4-BE9B-4110-ABD1-C1D96343B604Q34682589-743CD9F9-997E-49C7-9E56-6BBD11721B43Q34682688-758F5059-A756-4FFD-B451-EBD6D6F9A144Q34690050-AFB41BEB-1277-4362-B9C9-E10A178F1DCFQ34956921-56234C42-EE33-4655-AF61-C2FFA2D7BD9FQ34981937-307B8690-6AEB-4D02-87F1-1FC6BAD2C727Q35132422-2586B0D6-8423-44F1-AFC2-D6962B2B1666Q35172179-78E2E99A-F0E3-4468-B69A-1C09C72A0E66Q35506589-36C92A59-A8B5-48B1-A3CA-B656DD9365BDQ35549316-E1029BCB-415D-4471-9BDE-96EDDF7F8482Q35590457-4D1D2BFE-8108-4A4D-B0B9-8D9805A83215Q35608913-E990FE46-E65C-4A4F-9F47-2870B6DA01F8Q35794715-C2601B58-1E62-493C-AED1-E69EAD7B7838Q36068009-C59BDA06-7AAD-47D9-BF0B-76A7A923441E
P2860
Neonate characteristics after maternal use of antidepressants in late pregnancy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@en
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@nl
type
label
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@en
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@nl
prefLabel
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@en
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@nl
P1433
P1476
Neonate characteristics after maternal use of antidepressants in late pregnancy.
@en
P2093
Bengt Källén
P304
P356
10.1001/ARCHPEDI.158.4.312
P407
P577
2004-04-01T00:00:00Z